Antiangiogennaya terapiyapri rake molochnoy zhelezys troynym negativnym fenotipom by L G Zhukova

Get full text

Dlitel'noe i bezopasnoe primenenie Avastina pri metastaticheskom kolorektal'nom rake: klinicheskiy opyt primeneniya by L G Zhukova

Get full text

Bevatsizumab v lechenii HER2-negativnogometastaticheskogo raka molochnoy zhelezy:sovremennye dannye ob effektivnostii bezopasnosti by L G Zhukova

Get full text

Current approaches to therapy for complications of bone metastases from breast cancer by L. G. Zhukova

Get full text

Bevatsizumab (Avastin) v kombinatsii s taksanami v 1-y linii lecheniya HER-2-negativnogo metastaticheskogo raka molochnoy zhelezy(Rezul'taty issledovaniya AVADO) by L G Zhukova

Get full text

Postneoadjuvant therapy: a new approach to the treatment of HER2-positive breast cancer (KATHERINE study results) by L. G. Zhukova, S. A. Smolin

Get full text

Development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype by E V Karabina, L G Zhukova

Get full text

Sovremennye aspektyprofilaktiki neytropeniipri khimioterapii solidnykh opukholey by M E Abramov, L G Zhukova

Get full text

The place of CDK4/6 inhibitors in real clinical practice for patients with hormone-positive HER2-negative advanced breast cancer: opinion of Moscow’s oncologists by L. G. Zhukova, M. A. Mukhina

Get full text

The prospects for cisplatin and nab-paclitaxel combination therapy in patients with pre-treated triple-negative breast cancer. Description of the clinical case. by L. G. Zhukova, K. S. Bardovskaya, E. V. Lubennikova, I. R. Suslova

Get full text

Ribociclib in 1st line HR+ breast cancer treatment by L G Zhukova, I P Ganshina, O O Gordeeva, E V Lubennikova

Get full text

Opyt dlitel'nogo primeneniya kombinatsii kapetsitabina, lapatiniba i trastuzumabapri HER-2-pozitivnom metastaticheskom rake molochnoy zhelezy. Opisanie klinicheskogo sluchaya by L G Zhukova, M A Okruzhnova, E V Lubennikova, K R Zeynalova

Get full text

Assessment of the receptor status in primary breast cancer with synchronous loco regional metastases: prognostic and clinical role? by O. O. Gordeeva, L. G. Zhukova, I. V. Kolyadina, I. P. Ganshina

Get full text

Early and late postoperative complications of robot-assisted radical subcutaneous mastectomy with endoprosthesis by G. E.  Kvetenadze, E. V. Shivilov, Kh. S. Arslanov, L.  G. Zhukova, I.  E. Khatkov

Get full text

Olaparib in the metastatic HER2-negative breast cancer setting by L. G. Zhukova, E. I. Khatkova, I. P. Ganshina, I. V. Kolyadina, E. V. Lubennikova

Get full text

Klinicheskaya effektivnost'i bezopasnost' primeneniya otechestvennogo rekombinantnogo granulotsitarnogo koloniestimuliruyushchego faktora Neypomaks® u bol'nykh rakom molochnoy zhel... by L G Zhukova, M E Abramov, Yu V Vakhabova, A N Lud, A A Obukhov, M R Lichinitser

Get full text

Role of palbociclib in the treatment of hormone receptor-positive HER2-negative metastatic breast cancer. Generalizing results of randomized trials and real clinical practice by L. G. Zhukova, E. I. Khatkova, P. S. Feoklistova, K. S. Grechukhina, S. A. Smolin, E. A. Arutyunyan, E. M. Kolyago

Get full text

Pharmacogenetic testing of allelic variants of the CYP2D6 gene in hormone positive breast cancer by L. N. Lyubchenko, M. G. Filippova, T. A. Shendrikova, L. G. Zhukova, N. I. Mekhtieva, O. V. Krokhina, S. M. Portnoy

Get full text

The use of regorafenib in patients with disseminated gastrointestinal stromal tumours. A review of the literature. A clinical case by D. A. Filonenko, S. V. Petukhova, E. I. Khatkova, K. A. Vorontsova, E. I. Chichikov, B. M. Medvedeva, L. G. Zhukova

Get full text

Target therapy of luminal HER2-negative advanced breast cancer with PIK3CA mutation: combination of alpelisib plus fulvestrant in real clinical practice by D. A. Filonenko, T. M. Ibragimova, N. I. Polshina, A. V. Belogurova, E. I. Khatkova, E. A. Arutiunian, E. I. Volkova, L. G. Zhukova

Get full text